Solventum Corp. Files Q2 2024 10-Q Report
Ticker: SOLV · Form: 10-Q · Filed: 2024-08-09T00:00:00.000Z
Sentiment: neutral
Topics: spin-off, 10-Q, healthcare, medical-devices
Related Tickers: MMM
TL;DR
Solventum's Q2 10-Q is in. Standalone reporting begins.
AI Summary
Solventum Corp. reported its financial results for the period ending June 30, 2024. The company, formerly part of 3M Health Care Co., is a new entity incorporated in Delaware. Specific financial figures such as revenue, net income, or cash flow are not detailed in this excerpt, but the filing indicates it is a 10-Q report for the second quarter of 2024.
Why It Matters
This filing provides the first official financial reporting for Solventum Corp. as a standalone entity, crucial for investors and analysts tracking its performance post-spin-off from 3M.
Risk Assessment
Risk Level: medium — As a newly spun-off entity, Solventum faces inherent risks related to establishing its own operations, market position, and financial independence.
Key Numbers
- 2024 Q2 — Reporting Period (Indicates the financial quarter covered by the report.)
Key Players & Entities
- Solventum Corp. (company) — Filer of the 10-Q report.
- 3M Company (company) — Former parent company.
- 3M Health Care Co. (company) — Former name of the entity before spin-off.
- 20240630 (date) — End of the reporting period.
- 20240809 (date) — Filing date of the report.
FAQ
What is the primary business of Solventum Corp.?
Solventum Corp. is in the Surgical & Medical Instruments & Apparatus industry, SIC code 3841.
When was Solventum Corp. incorporated?
Solventum Corp. was incorporated in Delaware (DE).
What was the former name of Solventum Corp.?
The former name was 3M Health Care Co., with a date of name change on 20230203.
What is the fiscal year end for Solventum Corp.?
The fiscal year end for Solventum Corp. is December 31 (1231).
What is the SEC file number for Solventum Corp.?
The SEC file number is 001-41968.
From the Filing
0001964738-24-000020.txt : 20240809 0001964738-24-000020.hdr.sgml : 20240809 20240809135410 ACCESSION NUMBER: 0001964738-24-000020 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 87 CONFORMED PERIOD OF REPORT: 20240630 FILED AS OF DATE: 20240809 DATE AS OF CHANGE: 20240809 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Solventum Corp CENTRAL INDEX KEY: 0001964738 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 922008841 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-41968 FILM NUMBER: 241191847 BUSINESS ADDRESS: STREET 1: C/O 3M COMPANY STREET 2: 3M CENTER, BUILDING 275-6W-02 CITY: ST. PAUL STATE: MN ZIP: 55144-1000 BUSINESS PHONE: 651-733-1110 MAIL ADDRESS: STREET 1: C/O 3M COMPANY STREET 2: 3M CENTER, BUILDING 275-6W-02 CITY: ST. PAUL STATE: MN ZIP: 55144-1000 FORMER COMPANY: FORMER CONFORMED NAME: 3M Health Care Co DATE OF NAME CHANGE: 20230203 10-Q 1 solv-20240630.htm 10-Q solv-20240630 FALSE 2024 Q2 0001964738 12/31 P18M P3Y P3Y P5Y P7Y P10Y P30Y P40Y P18M xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure solv:operatingSegment solv:series solv:plan solv:country solv:lawsuit solv:classAction solv:case solv:quiTamAction solv:employee 0001964738 2024-01-01 2024-06-30 0001964738 2024-06-30 0001964738 us-gaap:ProductMember 2024-04-01 2024-06-30 0001964738 us-gaap:ProductMember 2023-04-01 2023-06-30 0001964738 us-gaap:ProductMember 2024-01-01 2024-06-30 0001964738 us-gaap:ProductMember 2023-01-01 2023-06-30 0001964738 solv:SalesOfSoftwareAndRentalsMember 2024-04-01 2024-06-30 0001964738 solv:SalesOfSoftwareAndRentalsMember 2023-04-01 2023-06-30 0001964738 solv:SalesOfSoftwareAndRentalsMember 2024-01-01 2024-06-30 0001964738 solv:SalesOfSoftwareAndRentalsMember 2023-01-01 2023-06-30 0001964738 2024-04-01 2024-06-30 0001964738 2023-04-01 2023-06-30 0001964738 2023-01-01 2023-06-30 0001964738 2023-12-31 0001964738 us-gaap:CommonStockMember 2024-03-31 0001964738 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001964738 us-gaap:RetainedEarningsMember 2024-03-31 0001964738 solv:NetParentInvestmentMember 2024-03-31 0001964738 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001964738 2024-03-31 0001964738 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001964738 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0001964738 solv:NetParentInvestmentMember 2024-04-01 2024-06-30 0001964738 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001964738 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001964738 us-gaap:CommonStockMember 2024-06-30 0001964738 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001964738 us-gaap:RetainedEarningsMember 2024-06-30 0001964738 solv:NetParentInvestmentMember 2024-06-30 0001964738 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001964738 us-gaap:CommonStockMember 2023-03-31 0001964738 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001964738 us-gaap:RetainedEarningsMember 2023-03-31 0001964738 solv:NetParentInvestmentMember 2023-03-31 0001964738 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001964738 2023-03-31 0001964738 solv:NetParentInvestmentMember 2023-04-01 2023-06-30 0001964738 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0001964738 us-gaap:CommonStockMember 2023-06-30 0001964738 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001964738 us-gaap:RetainedEarningsMember 2023-06-30 0001964738 solv:NetParentInvestmentMember 2023-06-30 0001964738 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001964738 2023-06-30 0001964738 us-gaap:CommonStockMember 2023-12-31 0001964738 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001964738 us-gaap:RetainedEarningsMember 2023-12-31 0001964738 solv:NetParentInvestmentMember 2023-12-31 0001964738 us-gaap:AccumulatedOtherComprehensiveIncomeMember